Welcome
Support Centre
21 March 2013 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   news
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes
statistics

[ Print-friendly version ]
Evaluation of services for urinary dysfunction
ISRCTN ISRCTN94747416
DOI 10.1186/ISRCTN94747416
ClinicalTrials.gov identifier
EudraCT number
Public title Evaluation of services for urinary dysfunction
Scientific title
Acronym N/A
Serial number at source G9410491
Study hypothesis The objective of the phase I trial is to compare a new Continence Nurse Practitioner (CNP) led service with existing service provision for individuals with incontinence and lower urinary tract symptoms in terms of symptom severity, associated factors, impact and economic implications. Treatment in the nursing service lasts eight weeks. The new nursing service delivers a package of evidence based interventions for the provision of continence care which are protocol driven.
Lay summary
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Urinary dysfunction
Participants - inclusion criteria Urinary dysfunction measured on a postal questionnaire (incontinence, nocturia, frequent voiding, urinary urgency)
Participants - exclusion criteria 1. Pregnancy
2. Malignancy
3. Fistula
4. Those already in receipt of treatment
Anticipated start date 01/06/1996
Anticipated end date 31/03/2002
Status of trial Completed
Patient information material
Target number of participants 6000
Interventions 1. Existing service provision: general practitioners and primary health care team
2. Nurse led service provision: new service instituting evidence based assessment and interventions provided by specially trained nurses
Primary outcome measure(s) An independent interview is carried out 13 weeks and 26 weeks after randomisation in both arms of the trial . This measures symptom severity, associated factors, impact (social and psychological) and economic aspects of the condition.
Secondary outcome measure(s) Not provided at time of registration
Sources of funding Medical Research Council (UK)
Trial website
Publications Results on http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12133054
Contact name Dr  C  McGrother
  Address Department of Epidemiology and Public Health
University of Leicester
22-28 Princess Road West
  City/town Leicester
  Zip/Postcode LE1 2TP
  Country United Kingdom
  Email
Sponsor Medical Research Council (MRC) (UK)
  Address 20 Park Crescent
  City/town London
  Zip/Postcode W1B 1AL
  Country United Kingdom
  Tel +44 (0)20 7636 5422
  Fax +44 (0)20 7436 6179
  Email clinical.trial@headoffice.mrc.ac.uk
  Sponsor website: http://www.mrc.ac.uk
Date applied 25/10/2000
Last edited 12/09/2007
Date ISRCTN assigned 25/10/2000
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2013 ISRCTN unless otherwise stated.